HUT43106A - Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins - Google Patents

Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins

Info

Publication number
HUT43106A
HUT43106A HU8779A HU7987A HUT43106A HU T43106 A HUT43106 A HU T43106A HU 8779 A HU8779 A HU 8779A HU 7987 A HU7987 A HU 7987A HU T43106 A HUT43106 A HU T43106A
Authority
HU
Hungary
Prior art keywords
proteins
koding
flesh
producing
inhibitor activity
Prior art date
Application number
HU8779A
Other languages
English (en)
Other versions
HU204888B (en
Inventor
Regina Heinzel
Hans G Gassen
Ursula Seemueller
Heribert Appelhans
Werner Machleidt
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HUT43106A publication Critical patent/HUT43106A/hu
Publication of HU204888B publication Critical patent/HU204888B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HU8779A 1986-01-10 1987-01-09 Process for producing dns sequences coding proteins, vectors, transformed host cells and proteins having biological effectivity of i type husi inhibitor, as well as pharmaceutical preparatives containing said agents HU204888B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863600571 DE3600571A1 (de) 1986-01-10 1986-01-10 Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
HUT43106A true HUT43106A (en) 1987-09-28
HU204888B HU204888B (en) 1992-02-28

Family

ID=6291649

Family Applications (1)

Application Number Title Priority Date Filing Date
HU8779A HU204888B (en) 1986-01-10 1987-01-09 Process for producing dns sequences coding proteins, vectors, transformed host cells and proteins having biological effectivity of i type husi inhibitor, as well as pharmaceutical preparatives containing said agents

Country Status (16)

Country Link
US (1) US4845076A (hu)
EP (1) EP0232523B1 (hu)
JP (2) JP2533869B2 (hu)
AT (1) ATE88500T1 (hu)
AU (1) AU604003B2 (hu)
CA (1) CA1326216C (hu)
DE (2) DE3600571A1 (hu)
DK (1) DK11187A (hu)
ES (1) ES2054612T3 (hu)
HU (1) HU204888B (hu)
IE (1) IE61526B1 (hu)
IL (1) IL81221A0 (hu)
LT (1) LTIP1753A (hu)
LV (1) LV10490B (hu)
PT (1) PT84089B (hu)
ZA (1) ZA87141B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
US5851983A (en) * 1987-12-28 1998-12-22 Teijin Limited Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
US5900401A (en) * 1994-03-23 1999-05-04 Tokyo Tanabe Company Limited Remedy for respiratory-tract viral disease
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
EP1400247A1 (en) * 1999-07-01 2004-03-24 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
US6544740B1 (en) * 1999-07-01 2003-04-08 Reprogen, Inc. Treatment of endometriosis with antileukoprotease
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
WO2003018620A2 (en) * 2001-08-27 2003-03-06 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
GB2532488B (en) * 2014-11-21 2019-07-31 Univ Of The Western Cape Use of AMP1 or AMP8 to diagnose HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
ATE108205T1 (de) * 1984-12-06 1994-07-15 Synergen Biolog Inc Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.

Also Published As

Publication number Publication date
IE870055L (en) 1987-07-10
LTIP1753A (en) 1995-07-25
LV10490B (en) 1995-10-20
JP2659525B2 (ja) 1997-09-30
DE3600571A1 (de) 1987-08-06
PT84089B (pt) 1989-02-28
JP2533869B2 (ja) 1996-09-11
EP0232523B1 (de) 1993-04-21
JPS62259591A (ja) 1987-11-11
DE3688324D1 (de) 1993-05-27
ZA87141B (en) 1987-08-26
DK11187A (da) 1987-07-11
LV10490A (lv) 1995-02-20
CA1326216C (en) 1994-01-18
AU604003B2 (en) 1990-12-06
JPH07300500A (ja) 1995-11-14
IE61526B1 (en) 1994-11-16
ATE88500T1 (de) 1993-05-15
EP0232523A3 (en) 1988-12-07
DK11187D0 (da) 1987-01-09
AU6745287A (en) 1987-07-16
EP0232523A2 (de) 1987-08-19
HU204888B (en) 1992-02-28
PT84089A (en) 1987-02-01
ES2054612T3 (es) 1994-08-16
IL81221A0 (en) 1987-08-31
US4845076A (en) 1989-07-04

Similar Documents

Publication Publication Date Title
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DE3587939D1 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, dafür kodierende DNS und diese DNS verwendendes Testverfahren.
RU94046367A (ru) Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела
AU9058091A (en) Preparation of nucleic acid samples
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
AU3368497A (en) Human dnase i hyperactive variants
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
DE3586189D1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
GB2322132B (en) Keratinocyte growth factor-2 products
DE59005821D1 (de) Verfahren zur Herstellung von L-Isoleucin und dafür geeignete Mikroorganismen und rekombinante DNA.
DE3778158D1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ATE55411T1 (de) Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen.
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
ATE74503T1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
ATE65543T1 (de) Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
IT1276765B1 (it) Gene del cromosoma x umano e proteina codificata da detto gene.
ATE46360T1 (de) Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer.
ES8800984A1 (es) Un metodo para obtener adn que codifica factor de necrosis de tumores mutante

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee